These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 24849823)
1. Section 4. Further expanding the criteria for HCC in living donor liver transplantation: the Tokyo University experience. Tamura S; Sugawara Y; Kokudo N Transplantation; 2014 Apr; 97 Suppl 8():S17-20. PubMed ID: 24849823 [TBL] [Abstract][Full Text] [Related]
2. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience. Lee KW; Yi NJ; Suh KS Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825 [TBL] [Abstract][Full Text] [Related]
3. Living donor liver transplantation for hepatocellular carcinoma: the Japanese experience. Tamura S; Sugawara Y; Kokudo N Oncology; 2011; 81 Suppl 1():111-5. PubMed ID: 22212944 [TBL] [Abstract][Full Text] [Related]
4. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Sugawara Y; Tamura S; Makuuchi M Dig Dis; 2007; 25(4):310-2. PubMed ID: 17960065 [TBL] [Abstract][Full Text] [Related]
5. Living donor liver transplantation for hepatocellular carcinoma: results of prospective patient selection by Kyushu University Criteria in 7 years. Uchiyama H; Itoh S; Yoshizumi T; Ikegami T; Harimoto N; Soejima Y; Harada N; Morita K; Toshima T; Motomura T; Maehara Y HPB (Oxford); 2017 Dec; 19(12):1082-1090. PubMed ID: 28888776 [TBL] [Abstract][Full Text] [Related]
6. Living donor liver transplantation for hepatocellular carcinoma. Isik B; Ince V; Karabulut K; Kayaalp C; Yilmaz S Transplant Proc; 2012; 44(6):1713-6. PubMed ID: 22841251 [TBL] [Abstract][Full Text] [Related]
7. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation. Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623 [TBL] [Abstract][Full Text] [Related]
8. Living donor liver transplantation for hepatocellular carcinoma. Lee SG; Moon DB Recent Results Cancer Res; 2013; 190():165-79. PubMed ID: 22941020 [TBL] [Abstract][Full Text] [Related]
9. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis. Liang W; Wu L; Ling X; Schroder PM; Ju W; Wang D; Shang Y; Kong Y; Guo Z; He X Liver Transpl; 2012 Oct; 18(10):1226-36. PubMed ID: 22685095 [TBL] [Abstract][Full Text] [Related]
10. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation. Wai CT; Woon WA; Tan YM; Lee KH; Tan KC Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059 [TBL] [Abstract][Full Text] [Related]
11. Pilot study of living donor liver transplantation for patients with hepatocellular carcinoma exceeding Milan Criteria (Barcelona Clinic Liver Cancer extended criteria). Llovet JM; Pavel M; Rimola J; Diaz MA; Colmenero J; Saavedra-Perez D; Fondevila C; Ayuso C; Fuster J; Ginès P; Bruix J; Garcia-Valdecasas JC Liver Transpl; 2018 Mar; 24(3):369-379. PubMed ID: 29140601 [TBL] [Abstract][Full Text] [Related]
12. Effects of loco regional treatments before living donor liver transplantation on overall survival and recurrence-free survival in South Korean patients with hepatocellular carcinoma. Na GH; Kim EY; Hong TH; You YK; Kim DG HPB (Oxford); 2016 Jan; 18(1):98-106. PubMed ID: 26776857 [TBL] [Abstract][Full Text] [Related]
13. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: the controversies continue. Lee HS Dig Dis; 2007; 25(4):296-8. PubMed ID: 17960062 [TBL] [Abstract][Full Text] [Related]
14. Should the liver transplant criteria for hepatocellular carcinoma be different for deceased donation and living donation? Grant D; Fisher RA; Abecassis M; McCaughan G; Wright L; Fan ST Liver Transpl; 2011 Oct; 17 Suppl 2():S133-8. PubMed ID: 21634006 [No Abstract] [Full Text] [Related]
15. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio. Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512 [TBL] [Abstract][Full Text] [Related]
16. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma. Ninomiya M; Shirabe K; Facciuto ME; Schwartz ME; Florman SS; Yoshizumi T; Harimoto N; Ikegami T; Uchiyama H; Maehara Y J Am Coll Surg; 2015 Mar; 220(3):297-304.e3. PubMed ID: 25617912 [TBL] [Abstract][Full Text] [Related]
17. Factors affecting recurrence and survival after living donor liver transplantation for hepatocellular carcinoma. Abdel-Wahab M; Sultan AM; Fathy OM; Salah T; Elshobary MM; Elghawalby NA; Yassen AM; Elsarraf WM; Elsaadany MF; Zalatah K Hepatogastroenterology; 2013; 60(128):1847-53. PubMed ID: 24719918 [TBL] [Abstract][Full Text] [Related]